title: [Immunization with recombinant HBcAg and β-amyloid peptide fusion protein promotes clearance of intrahippocampally injected β-amyloid peptide in rats].
abstract: OBJECTIVE
  To study the effects of immunization with the fusion protein CAC (a product of prokaryotic expression of recombinant HBcAg and β-amyloid peptide fusion gene) against the toxicity induced by intrahippocampal injection of aggregated β-amyloid peptide (Aβ) in rats.
  
  
  METHODS
  SD rats were immunized intraperitoneally with the fusion protein CAC, and the titer of anti-Aβ antibody was evaluated by ELISA. When the titers of the anti-Aβ antibody reached 1:3 000, aggregated Aβ was injected into the CA1 region of the rat hippocampus. Two weeks after Aβ injection, the rats underwent morris water maze test before sacrificed to prepare the brain slices with Congo red and haematoxylin staining.
  
  
  RESULTS
  The titer of anti-Aβ antibody reached 1:3 000 after 5 immunizations with the fusion protein. After Aβ injection, the saline-immunized rats showed a reduced cognitive behavior in the Morris water maze test compared to the CAC-immunized rats. In the saline-immunized rats, the neurons around the site of Aβ injection exhibited obvious cell damages with Aβ deposits and glial infiltration, whereas in CAC-immunized rats, Aβ deposits were significantly reduced or even absent.
  
  
  CONCLUSIONS
  Immunization with the fusion protein CAC can inhibit the toxicity induced by intrahippocampal aggregated Aβ injection.
authors.affiliation: Department of Human Anatomy and Histoembryology, Xi'an Jiaotong University College of Medicine, Xi'an 710061, China. fenggaifeng@163.com
authors.forename: Gai-feng
authors.initials: GF
authors.lastname: Feng
authors.forename: Hai-tao
authors.initials: HT
authors.lastname: Hu
authors.forename: Hui
authors.initials: H
authors.lastname: Jin
authors.forename: Wei-xi
authors.initials: WX
authors.lastname: Wang
authors.forename: Yi-hua
authors.initials: YH
authors.lastname: Qian
mesh_terms: D016229:Amyloid beta-Peptides / Q000008:administration & dosage / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000097:blood*; D006512:Hepatitis B Core Antigens / Q000096:biosynthesis* / Q000235:genetics; D006624:Hippocampus / Q000378:metabolism; D007114:Immunization; D007267:Injections; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage / Q000276:immunology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*
chemical_list: D016229:Amyloid beta-Peptides; D000906:Antibodies; D006512:Hepatitis B Core Antigens; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins; C078592:amyloid beta-protein (1-40)